Literature DB >> 23679656

Peyronie's disease among men who have sex with men: characteristics, treatment, and psychosocial factors.

Michael Ryan Farrell1, Christopher J Corder, Laurence A Levine.   

Abstract

INTRODUCTION: We describe the characteristics of Peyronie's disease (PD) and its associated psychosocial implications in men who have sex with men (MSM). AIM: The aims of this article are to identify presenting characteristics and treatment for MSM with PD, compare these findings to non-MSM PD patients, and determine the psychosocial impact of PD among MSM. MAIN OUTCOME MEASURES: Subjective and objective presenting characteristics, MSM psychosocial factors.
METHODS: We identified 27 MSM with PD presenting from 2000 to 2012 through a retrospective chart review. A random selection of 200 non-MSM PD patients was identified, who presented during the same time period. A prospective nonvalidated questionnaire was given to MSM PD patients for evaluation of psychosocial constructs.
RESULTS: A traumatic event leading to activation of PD was identified equally among MSM and non-MSM (P = 0.815). Most common recognized activators of PD among MSM were: penetrative sexual intercourse (22.2%), self-stimulation (11.1%). More MSM presented with the primary complaint of penile deformity, including narrowing, indentation, hourglass, and hinge (11.1% MSM vs. 1.0% non-MSM, P = 0.01). No differences in total curvature, erection grade were found (P > 0.05). PD had a negative effect on emotional status (89.0% MSM, 80.5% non-MSM, P > 0.05) and intimate relationships (45.0% MSM, 64.0% non-MSM, P > 0.05). Nonsurgical treatment was given to 88.9% MSM and 76.5% non-MSM (P > 0.05), and corrective surgery in 29.6% MSM and 25.0% non-MSM (P > 0.05). Of the 75.0% of MSM engaging in anal sex, 41.7% reported penetrative anal intercourse as the activator of PD. Among MSM, 31.3% experienced decreased libido, 50.0% decreased frequency of sexual activity, 92.9% were self-conscious about the appearance of their penis, and 92.9% were dissatisfied with the size of their penis.
CONCLUSIONS: Few differences exist in the clinical presentation and treatments used between MSM and non-MSM PD patients. There was evidence of emotional distress in both groups. As a result, psychosexual assessment and treatment, when indicated, should be considered essential to the patient presenting with PD.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  Characteristics; Men Who Have Sex with Men; Peyronie's Disease; Psychosocial Factors; Treatment; Tunica Albuginea of the Corpora Cavernosa

Mesh:

Year:  2013        PMID: 23679656     DOI: 10.1111/jsm.12202

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  10 in total

1.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

Review 2.  Sexual Dysfunction Among Men Who Have Sex with Men: a Review Article.

Authors:  Raul E Fernandez-Crespo; Billy H Cordon-Galiano
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

3.  Satisfaction rates of inflatable penile prosthesis in men who have sex with men are high.

Authors:  Justin La; Charles A Loeb; David W Barham; Jake Miller; Eric Chung; Martin S Gross; Georgios Hatzichristodoulou; Sung Hun Park; Paul E Perito; Alfredo Suarez-Sarmiento; Koenraad Van Renterghem; Faysal A Yafi
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

4.  Defining the impact of Peyronie's disease on the psychosocial status of gay men.

Authors:  Carolyn A Salter; Bruno Nascimento; Jean-Etienne Terrier; Hisanori Taniguchi; Helen Bernie; Eduardo Miranda; Lawrence Jenkins; Elizabeth Schofield; John P Mulhall
Journal:  Andrology       Date:  2020-10-10       Impact factor: 3.842

Review 5.  Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation.

Authors:  Madeleine G Manka; Lindsay A White; Faysal A Yafi; John P Mulhall; Laurence A Levine; Matthew J Ziegelmann
Journal:  J Sex Med       Date:  2021-01-07       Impact factor: 3.802

Review 6.  Psychosexual Symptoms and Treatment of Peyronie's Disease Within a Collaborative Care Model.

Authors:  Rose Hartzell
Journal:  Sex Med       Date:  2014-12       Impact factor: 2.491

Review 7.  ESSM Position Statement on Surgical Treatment of Peyronie's Disease.

Authors:  Daniar Osmonov; Ahmed Ragheb; Sam Ward; Gideon Blecher; Marco Falcone; Armin Soave; Roland Dahlem; Koenraad van Renterghem; Nim Christopher; Georgios Hatzichristodoulou; Mirko Preto; Giulio Garaffa; Maarten Albersen; Carlo Bettocchi; Giovanni Corona; Yacov Reisman
Journal:  Sex Med       Date:  2021-11-22       Impact factor: 2.491

Review 8.  Psychological aspects of Peyronie's disease.

Authors:  Jean E Terrier; Christian J Nelson
Journal:  Transl Androl Urol       Date:  2016-06

9.  A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.

Authors:  L Toscano; M V Rezende; L F Mello; D Paulillo; S Glina
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

10.  Beyond Curvature: Prevalence and Characteristics of Penile Volume-Loss Deformities in Men With Peyronie's Disease.

Authors:  Ezra J Margolin; Matthew J Pagano; Carrie M Aisen; Ifeanyi C Onyeji; Peter J Stahl
Journal:  Sex Med       Date:  2018-10-17       Impact factor: 2.491

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.